Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Conditions
Beta-Thalassemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Local Institution - 601, Los Angeles, California, United States
New York Presbyterian Hospital, New York, New York, United States
Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
Contact: Study coordinator (Xiaoqin Feng)Shenzhen Second People's Hospital, Shenzhen, Guangdong, China
People's Liberation Army The 923rd Hospital, Nanning, GX, China
West China Hospital - Sichuan University, Chengdu, Sichuan, China
Contact: Study coordinator (Ju Gao)Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
The First Affiliated Hospital of Guangxi Medical University, Nanning, China
Universitätsklinikum Essen, Essen, Germany
Contact: Study coordinator (Carmen Aramayo-Singelmann)Universitatsklinikum Ulm, Ulm, Germany
General Children's Hospital "Agia Sophia", Athens, Greece
Kamala Hospital and Research Center, Hyderabad, Andhra Pradesh, India
Contact: Study coordinator (Suman Jain)MCGM - Comprehensive Thalassemia Care, Pediatric Hematology-Oncology & BMT Centre, Borivali (E), Mumbai, Maharashtra, India
Contact: Study coordinator (Mamta V Manglani)Kingsway Hospitals, Nagpur, Maharashtra, India
Contact: Study coordinator (Riya Ballikar)Post Graduate Institute of Child Health, Noida, Uttar Pradesh, India
Local Institution - 803, Kolkata, India
Christian Medical College & Hospital, Vellore, India
Contact: Study coordinator (Aby Abraham)Ospedale Pediatrico Bambino Gesù IRCCS, Rome, Roma, Italy
Ente Ospedaliero Ospedali Galliera - Centro della Microcitemia e delle Anemie Congenite, Genoa, Italy
AOU dell'Universita degli Studi della Campania Luigi Vanvitelli, Naples, Italy
Azienda Ospedaliero Universitaria S. Luigi Gonzaga, Orbassano, Italy
Contact: Study coordinator (Giovanni Battista Ferrero)Local Institution - 700, Beirut, Lebanon
Chulalongkorn University Faculty of Medicine - King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Contact: Study coordinator (Darintr Sosothikul)Siriraj Hospital Mahidol University, Bangkok, Thailand
Ramathibodi Hospital, Mahidol University, Phyathai, Thailand
Contact: Study coordinator (Duantida Songdej)Local Institution - 401, Izmir, Turkey (Türkiye)
Study leads
Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb